Immunotherapy biomarkers 2016: Overcoming the barriers

James L. Gulley, Jay A. Berzofsky, Marcus O. Butler, Alessandra Cesano, Bernard A. Fox, Sacha Gnjatic, Sylvia Janetzki, Shyam Kalavar, Vaios Karanikas, Samir N. Khleif, Ilan Kirsch, Peter P. Lee, Cristina Maccalli, Holden Maecker, Jeffrey Schlom, Barbara Seliger, Janet Siebert, David F. Stroncek, Magdalena Thurin, Jianda YuanLisa H. Butterfield

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


This report summarizes the symposium, 'Immunotherapy Biomarkers 2016: Overcoming the Barriers', which was held on April 1, 2016 at the National Institutes of Health in Bethesda, Maryland. The symposium, cosponsored by the Society for Immunotherapy of Cancer (SITC) and the National Cancer Institute (NCI), focused on emerging immunotherapy biomarkers, new technologies, current hurdles to further progress, and recommendations for advancing the field of biomarker development.

Original languageEnglish (US)
Article number29
JournalJournal for ImmunoTherapy of Cancer
Issue number1
StatePublished - Mar 21 2017


  • Baseline measures
  • Biomarkers
  • High throughput
  • Immune monitoring
  • Immunotherapy
  • Tumor microenvironment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research


Dive into the research topics of 'Immunotherapy biomarkers 2016: Overcoming the barriers'. Together they form a unique fingerprint.

Cite this